X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-19 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $13.95 | -100,000 | 11,565,600 | -1% | -$1,394,960 | ||||||
2024-11-12 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $16.85 | -100,000 | 12,967,049 | -1% | -$1,684,642 | ||||||
2024-10-15 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $14.88 | -100,000 | 11,765,600 | -1% | -$1,487,595 | ||||||
2024-10-08 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $13.83 | -100,000 | 11,865,600 | -1% | -$1,382,775 | ||||||
2024-09-17 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $12.93 | -100,000 | 11,965,600 | -1% | -$1,293,205 | ||||||
2024-09-10 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $11.50 | -100,000 | 12,065,600 | -1% | -$1,149,775 | ||||||
2024-08-20 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $15.03 | -100,000 | 12,165,600 | -1% | -$1,502,587 | ||||||
2024-08-13 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $12.48 | -100,000 | 13,747,495 | -1% | -$1,247,555 | ||||||
2024-07-16 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $11.40 | -100,000 | 12,365,600 | -1% | -$1,140,295 | ||||||
2024-07-09 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.62 | -100,000 | 12,465,600 | -1% | -$961,725 | ||||||
| M | 2024-06-11 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.14 | -100,000 | 12,565,600 | -1% | -$913,917 | |||||
| M | 2024-05-14 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.05 | -100,000 | 12,665,600 | -1% | -$905,441 | |||||
2024-05-07 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.34 | -100,000 | 12,765,600 | -1% | -$934,365 | ||||||
2024-04-16 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.28 | -100,000 | 12,546,116 | -1% | -$928,005 | ||||||
2024-04-09 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.28 | -100,000 | 12,646,116 | -1% | -$927,735 | ||||||
| M | 2024-03-22 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.12 | -97,610 | 12,746,116 | -1% | -$890,322 | |||||
| M | 2024-03-19 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.03 | -2,390 | 12,843,726 | 0% | -$21,572 | |||||
| M | 2024-03-13 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.14 | -100,000 | 12,846,116 | -1% | -$913,681 | |||||
2024-02-29 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.02 | -3,782 | 12,946,116 | 0% | -$34,101 | ||||||
| M | 2024-02-26 | SPRY | Tanimoto Sarina | Chief Medical Officer, 10% | S - Sale | $9.02 | -99,478 | 12,949,898 | -1% | -$897,368 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |